Ibnsina Pharma (EGX: ISPH)

Ibnsina Pharma Revenue

Ibnsina Pharma had revenue of 15.59B EGP in the quarter ending September 30, 2024, with 71.14% growth. This brings the company's revenue in the last twelve months to 48.55B, up 60.44% year-over-year. In the year 2023, Ibnsina Pharma had annual revenue of 33.95B with 52.48% growth.

• Revenue (ttm): 48.55B
• Revenue Growth: +60.44%
• P/S Ratio: 0.13
• Revenue / Employee: 8.83M
• Employees: 5,500
• Market Cap: 6.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	33.95B	11.68B	52.48%
Dec 31, 2022	22.26B	531.66M	2.45%
Dec 31, 2021	21.73B	3.05B	16.35%
Dec 31, 2020	18.68B	2.08B	12.52%
Dec 31, 2019	16.60B	3.28B	24.59%